In summary, an essential function of the KITENIN homodimer is maintaining its stability and thereby providing a docking site for key interaction partners, and our findings propose a new strategy for developing a peptide cancer therapeutic to specifically block the colorectal liver metastasis driven by the higher levels of oncogenic KITENIN. The gene discussed is VANGL1; the disease is cancer.